Healthcare providers depend upon multiple tools to diagnose conditions and guide treatment decisions. One of the most widely used is in vitro diagnostics (IVD), which are clinical tests that analyse samples taken from the human body to detect disease, conditions, and infections. In vitro simply means ‘in glass,’ which means that these tests are conducted in test tubes and similar equipment. The tests can be performed on a variety of instruments ranging from small handheld tests to complex laboratory instruments. And this allows doctors to diagnose patients effectively and in turn refer the required treatments.
Over 40,000 products are available currently for IVD testing, covering a variety of conditions. The samples are sent to a central laboratory for analysis and point-of-care tests, which are performed near, or at the point of patient care. Point-of-care testing helps optimize treatment decision-making, avoid referrals, improve the efficiency of care and decrease costs, especially in resource-constrained settings where laboratory infrastructure is weak. Diagnostic tests are increasingly important around the world as a first defence against the spread of many diseases. The fight against tuberculosis, for example, relies on modern diagnostics as a prerequisite for the early, rapid and accurate detection of the disease and changes in drug resistance used in its treatment. IVD are also the first line of defence against the possibility of the re-emergence of eradicated diseases. Smallpox, for example, is unlikely to reappear; however, WHO maintains a network of partnerships around the world dedicated to the rapid diagnosis and containment of any potential cases.
Growth of global IVD market is driven by rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing. Development of condition-specific markers and tests and growing demand for IVD products in emerging countries provides significant opportunities for the various stakeholders in this market.
At this juncture, there is a wide variety of solutions providers entering the industry with a set of advanced IVD offerings. To help navigate through the best-of-breed in vitro diagnostic solution providers, MedTech Outlook has compiled a list of ‘Top 10 In Vitro Diagnostic Solution Providers in APAC– 2020.’ Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CIOs.
We present to you MedTech Outlook’s “Top 10 In Vitro Diagnostic Solution Providers in APAC– 2020.”
